Therefore, although plasma BDNF may be a valuable biomarker for the treatment of depression, it may not be appropriate or feasible to establish a normal range (as is done for numerous other serum components to establish a baseline for assessing physiological status). This evidence concerns the gene BDNF and major depressive disorder.